Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
Construction and validation of the chronic acquired polyneuropathy patient-reported index, "CAP-PRI:" a disease-specific, health-related quality of life instrument.
Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis.
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes.
Therapeutic Advances in Pediatric Multiple Sclerosis.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
Endocannabinoid signalling and the deteriorating brain.
Genomic medicine and risk prediction across the disease spectrum.
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
Regulatory B Cells and Mechanisms.
Central motor conduction time.
Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Modeling the course and outcomes of MS is statistical twaddle-No.
Epstein-Barr virus in multiple sclerosis.
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): A single case report follow-up study.
Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
Fiber-Optic Bronchoscopy and Volume-Cycled Mouthpiece Ventilation for a Patient with Multiple Sclerosis and Ventilatory Failure.
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.
L-periaxin interacts with S-periaxin through its PDZ domain.
Pages
« first
‹ previous
…
597
598
599
600
601
602
603
604
605
…
next ›
last »